Literature DB >> 3595689

Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.

O P Kallioniemi, T Hietanen, J Mattila, M Lehtinen, K Lauslahti, T Koivula.   

Abstract

The prognostic impact of DNA content and S-phase fraction (SPF) of tumour cells was studied in 93 patients with primary breast cancer. Aneuploid DNA content and high SPF were clearly associated with poor differentiation state of tumours and absence of steroid, especially progesterone receptors. Aneuploidy and high SPF tended to become more common with increasing primary tumour size, with more extensive nodal involvement and with more advanced stage of the cancer. Patients with diploid tumours had a slightly longer disease-free interval and survival than those with aneuploid tumours, whereas below median SPF as compared to above median SPF was associated with significantly longer (P less than 0.01) relapse-free interval and survival in patients with stage II-III cancer. We conclude that the DNA analysis of tumour cells is a promising method for the estimation of prognosis in breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595689     DOI: 10.1016/0277-5379(87)90071-x

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  34 in total

1.  Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity.

Authors:  W L Lingle; W H Lutz; J N Ingle; N J Maihle; J L Salisbury
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

2.  Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: correlation and relative prognostic influence.

Authors:  T Hatschek; O Gröntoft; G Fagerberg; O Stål; S Sullivan; J Carstensen; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

3.  Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.

Authors:  K Jirström; L Rydén; L Anagnostaki; B Nordenskjöld; O Stål; S Thorstenson; G Chebil; P-E Jönsson; M Fernö; G Landberg
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

4.  Cellular effects of tamoxifen in primary breast cancer.

Authors:  J F Robertson; I O Ellis; R I Nicholson; A Robins; J Bell; R W Blamey
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

5.  Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

Authors:  A von Rosen; L E Rutqvist; J Carstensen; A Fallenius; L Skoog; G Auer
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

6.  Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.

Authors:  S M Siitonen; O P Kallioniemi; J J Isola
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

7.  Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer.

Authors:  Anand Vasudevan; Prasamit S Baruah; Joan C Smith; Zihua Wang; Nicole M Sayles; Peter Andrews; Jude Kendall; Justin Leu; Narendra Kumar Chunduri; Dan Levy; Michael Wigler; Zuzana Storchová; Jason M Sheltzer
Journal:  Dev Cell       Date:  2020-02-24       Impact factor: 12.270

8.  Nuclear DNA content of non-endemic Burkitt's lymphoma.

Authors:  T Lehtinen; M Lehtinen; R Aine; O P Kallioniemi; T Leino; T Hakala; P Leinikki; M Alavaikko
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

9.  Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.

Authors:  S A Brooks; A J Leathem; R S Camplejohn; W Gregory
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.

Authors:  L Pedersen; J K Larsen; I J Christensen; A Lykkesfeldt; S Holck; T Schiødt
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.